Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Amthauer

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2017
Proof of Therapeutic Efficacy of a <sup>177</sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft ModelJörg Schulz, Martin Rohracker, Marvin Stiebler, et al.
Plos One|May 16, 2019
The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATEChristoph Wetz, Philipp Genseke, Ivayla Apostolova, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastasesIngo G Steffen, Peter Wust, Ricarda Rühl, et al.
Acta Radiologica Open|July 2, 2019
Iterative CT reconstruction in abdominal low-dose CT used for hybrid SPECT-CT applications: effect on image quality, image noise, detectability, and reader's confidenceOliver S Grosser, Juri Ruf, Dennis Kupitz, et al.
Pediatric Blood & Cancer|December 23, 2011
SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET?Christian Furth, Robert M Meseck, Ingo G Steffen, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2011
[Radioembolization with (90)Y-labeled microspheres: post-therapeutic therapy validation with Bremsstrahlung-SPECT]Oliver S Grober, Madeleine Nultsch, Kathleen Laatz, et al.
Academic Radiology|October 6, 2014
Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agentsJan H Rothe, Ines Rudolph, Nadine Rohwer, et al.
Cancers|November 11, 2022
Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic ScoreImke Schatka, Hans V Jochens, Julian M M Rogasch, et al.
Clinical Lung Cancer|December 17, 2019
Validation of Independent Prognostic Value of Asphericity of <sup>18</sup>F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative IntentJulian M M Rogasch, Christian Furth, Christoph Chibolela, et al.
F1000Research|April 5, 2021
PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot studyJulian Rogasch, Marcus Beck, Carmen Stromberger, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2017
Proof of Therapeutic Efficacy of a <sup>177</sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft ModelJörg Schulz, Martin Rohracker, Marvin Stiebler, et al.
Plos One|May 16, 2019
The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATEChristoph Wetz, Philipp Genseke, Ivayla Apostolova, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastasesIngo G Steffen, Peter Wust, Ricarda Rühl, et al.
Acta Radiologica Open|July 2, 2019
Iterative CT reconstruction in abdominal low-dose CT used for hybrid SPECT-CT applications: effect on image quality, image noise, detectability, and reader's confidenceOliver S Grosser, Juri Ruf, Dennis Kupitz, et al.
Pediatric Blood & Cancer|December 23, 2011
SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET?Christian Furth, Robert M Meseck, Ingo G Steffen, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2011
[Radioembolization with (90)Y-labeled microspheres: post-therapeutic therapy validation with Bremsstrahlung-SPECT]Oliver S Grober, Madeleine Nultsch, Kathleen Laatz, et al.
Academic Radiology|October 6, 2014
Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agentsJan H Rothe, Ines Rudolph, Nadine Rohwer, et al.
Cancers|November 11, 2022
Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic ScoreImke Schatka, Hans V Jochens, Julian M M Rogasch, et al.
Clinical Lung Cancer|December 17, 2019
Validation of Independent Prognostic Value of Asphericity of <sup>18</sup>F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative IntentJulian M M Rogasch, Christian Furth, Christoph Chibolela, et al.
F1000Research|April 5, 2021
PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot studyJulian Rogasch, Marcus Beck, Carmen Stromberger, et al.
Pageof 21